Exploratory pilot study assessing the risk of cognitive impairment or sedation in the elderly following single doses of solifenacin 10 mg

…, C Edgar, RN Tretter, J Bolodeoku - Expert opinion on drug …, 2009 - Taylor & Francis
Objectives: To assess the cognitive effects of single doses of solifenacin 10 mg compared
with placebo (primary objective) and oxybutynin immediate release (IR) 10 mg (secondary …

A comparison of the efficacy and tolerability of solifenacin succinate and extended release tolterodine at treating overactive bladder syndrome: results of the STAR trial

…, W Warnack, T Drogendijk, DM Wright, J Bolodeoku… - European urology, 2005 - Elsevier
OBJECTIVE:: To compare two new generation antimuscarinics at their recommended doses
for treatment of overactive bladder syndrome (OAB). METHODS:: A prospective, double …

Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urine

…, T Sugino, H Tahara, A Woodman, J Bolodeoku… - Cancer, 1997 - Wiley Online Library
BACKGROUND Telomerase is an enzyme that can reconstitute the ends (telomeres) of
chromosomes after cell division and thus circumvent the cumulative damage that occurs in …

Solifenacin in the treatment of urgency and other symptoms of overactive bladder: results from a randomized, double‐blind, placebo‐controlled, rising‐dose trial

…, T Drogendijk, M Wright, J Bolodeoku… - BJU …, 2008 - Wiley Online Library
OBJECTIVES To examine the effects of the antimuscarinic agent solifenacin on urinary
urgency, using a range of novel and established outcome measures, as urgency is the …

Progressive loss of CD44 gene expression in invasive bladder cancer.

…, H Gorham, K Yoshida, J Bolodeoku… - The American journal …, 1996 - ncbi.nlm.nih.gov
This study investigated CD44 gene expression at both the RNA and protein level in well
differentiated superficial and in deeply invasive bladder carcinomas. Proteins were studied …

The impact of tamsulosin oral controlled absorption system (OCAS) on nocturia and the quality of sleep: preliminary results of a pilot study

B Djavan, S Milani, J Davies, J Bolodeoku - European Urology …, 2005 - Elsevier
OBJECTIVES:: This randomised, double-blind, placebo-controlled, 8-week exploratory study
was designed to assess the effect of the new formulation of tamsulosin (oral controlled …

Treatment outcomes in the STAR study: a subanalysis of solifenacin 5 mg and tolterodine ER 4 mg

…, J Rosa, RM Scarpa, A Mistry, DM Wright, J Bolodeoku… - european urology, 2007 - Elsevier
OBJECTIVE: To compare OAB symptom outcomes following initial randomised treatment
with solifenacin 5mg or tolterodine ER 4mg at the 4-week clinic-visit and again at 12 weeks …

A randomized double‐blind placebo‐controlled multicentre study to explore the efficacy and safety of tamsulosin and tolterodine in women with overactive bladder …

…, L Cardozo, G Terpstra, J Bolodeoku… - BJU …, 2007 - Wiley Online Library
OBJECTIVES To evaluate the efficacy of tamsulosin oral‐controlled absorption system
(OCAS) vs placebo in overactive bladder (OAB), to evaluate the safety and tolerability of …

Telomerase activity in human breast cancer and benign breast lesions: diagnostic applications in clinical specimens, including fine needle aspirates

T Sugino, K Yoshida, J Bolodeoku… - … journal of cancer, 1996 - Wiley Online Library
We analysed telomerase activity in normal, benign and malignant breast tissues and in fine
needle aspirates by a PCR‐based assay. The tissue samples we used in this assay …

Urinalysis in clinical diagnosis.

J Bolodeoku, D Donaldson - Journal of clinical pathology, 1996 - ncbi.nlm.nih.gov
It is appropriate to commence this article on the history of urine examination with the words
of Auguste Comte (1798-1857), who wrote in Positive Philosophy that" To understand a …